iSERA Lifesciences Ltd vs LTM Ltd

A side-by-side comparison of iSERA Lifesciences Ltd (ISERA) and LTM Ltd (LTM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, LTM Ltd leads ISERA vs LTM on 12 of 14 metrics (2 tied). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

846.47
P/E ratio
23.91
14.67
P/B ratio
4.54
0.00%
Dividend yield
1.85%
₹0.17
EPS
₹169.25

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

-8.82%
Return on equity
23.10%
19.05%
Return on capital
30.00%
0.00%
EBITDA margin
18.00%
0.00%
Net margin
11.78%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

Revenue CAGR (3Y)
8.43%
Profit CAGR (3Y)
4.16%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹121 Cr
Market cap
₹1.21L Cr
₹0 Cr
Revenue
₹42,308 Cr
₹0 Cr
Net profit
₹4,983 Cr
0.20
Debt / equity
0.10
iSERA Lifesciences Ltd
  • ["Stock is trading at 14.7 times its book value", "Company has high debtors of 322 days.", "Promoter holding has decreased over last 3 years: -41.4%"]
LTM Ltd
  • + ["Company has a good return on equity (ROE) track record: 3 Years ROE 23.1%", "Company has been maintaining a healthy dividend payout of 42.7%", "Company's working capital requirements have reduced from 33.8 days to 26.4 days"]
iSERA Lifesciences Ltd full analysis LTM Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.